Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement

GlobeNewswire Inc. | Sep 17, 2026 9:26 AM EDT

Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases